HARMONY BIOSCIENCES HOLDINGS (HRMY) Stock Analyst Earnings Estimates
NASDAQ:HRMY - Nasdaq - US4131971040 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 437.9M 43.39% | 582.022M 32.91% | 714.734M 22.80% | 860.9M 20.45% | 1.01B 17.32% | 1.164B 15.25% | 1.432B 23.02% | 1.683B 17.53% | 1.698B 0.89% | 1.019B -39.99% | 954.41M -6.34% | |
| EBITDA YoY % growth | 143.6M 35.09% | 216.389M 50.69% | 214.938M -0.67% | 310.22M 44.33% | 392.4M 26.49% | 462.77M 17.93% | 519.8M 12.32% | 636.82M 22.51% | 679.47M 6.70% | 332.93M -51.00% | 281.11M -15.56% | |
| EBIT YoY % growth | 120.2M 37.37% | 192.03M 59.76% | 190.826M -0.63% | 262.55M 37.59% | 346.32M 31.91% | 486.07M 40.35% | 534.71M 10.01% | 697.72M 30.49% | 673.76M -3.43% | 330.38M -50.96% | 278.77M -15.62% | |
| Operating Margin | 27.45% | 32.99% | 26.70% | 30.50% | 34.29% | 41.76% | 37.34% | 41.46% | 39.68% | 32.42% | 29.21% | |
| EPS YoY % growth | 3.13 277.11% | 2.42 -22.68% | 2.51 3.72% | 3.37 34.21% | 4.34 28.76% | 5.28 21.72% | 9.34 76.93% | 11.58 23.94% | 12.42 7.31% | 7.64 -38.51% | 6.83 -10.55% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.77 282.73% | 0.86 8.27% | 0.92 8.80% | 0.81 4.35% | 0.96 25.92% | 0.95 11.50% | 1.02 10.29% |
| Revenue Q2Q % growth | 207.68M 20.18% | 223.16M 19.95% | 240.29M 19.39% | 220.07M 19.13% | 249.42M 20.10% | 261.95M 17.38% | 275.37M 14.60% |
| EBITDA Q2Q % growth | 70.612M 40.74% | 76.908M -3.69% | 86.94M 8.89% | 76.612M 23.14% | 112.02M 58.64% | 121.13M 57.50% | 127.39M 46.53% |
| EBIT Q2Q % growth | 56.24M 48.00% | 62.834M 1.82% | 74.037M 32.86% | 66.976M 19.08% | 92.721M 64.87% | 95.767M 52.41% | 101.85M 37.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.78 16.42% | 0.60 | 0.18 | 31.00% |
| Q4 2024 Q2Q % growth | 0.85 88.89% | 0.75 | 0.10 | 12.80% |
| Q3 2024 Q2Q % growth | 0.79 5.33% | 0.68 | 0.11 | 16.47% |
| Q2 2024 Q2Q % growth | 0.20 -64.29% | -0.06 | 0.26 | 409.61% |
| Q1 2024 Q2Q % growth | 0.67 1.52% | 0.62 | 0.05 | 8.70% |
| Q4 2023 Q2Q % growth | 0.45 -43.04% | 0.49 | -0.04 | -7.85% |
| Q3 2023 Q2Q % growth | 0.75 -47.92% | 0.66 | 0.09 | 13.12% |
| Q2 2023 Q2Q % growth | 0.56 43.59% | 0.65 | -0.09 | -13.20% |
| Q1 2023 Q2Q % growth | 0.66 29.41% | 0.48 | 0.18 | 37.31% |
| Q4 2022 Q2Q % growth | 0.79 107.89% | 0.59 | 0.20 | 33.82% |
| Q3 2022 Q2Q % growth | 1.44 947.06% | 0.14 | 1.30 | 951.28% |
| Q2 2022 Q2Q % growth | 0.39 62.50% | 0.45 | -0.06 | -13.10% |
| Q1 2022 Q2Q % growth | 0.51 34.21% | 0.30 | 0.21 | 69.90% |
| Q4 2021 Q2Q % growth | 0.38 52.00% | 0.36 | 0.02 | 4.45% |
| Q3 2021 Q2Q % growth | -0.17 -21.43% | 0.30 | -0.47 | -157.47% |
| Q2 2021 Q2Q % growth | 0.24 | 0.18 | 0.06 | 33.18% |
| Q1 2021 Q2Q % growth | 0.38 | -0.03 | 0.41 | 1,496.88% |
| Q4 2020 Q2Q % growth | 0.25 | 0.09 | 0.16 | 172.33% |
| Q3 2020 Q2Q % growth | -0.14 | -0.05 | -0.09 | -174.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 184.733M 19.48% | 186.56M | -1.827M | -0.98% |
| Q4 2024 Q2Q % growth | 201.267M 19.51% | 205.01M | -3.743M | -1.83% |
| Q3 2024 Q2Q % growth | 186.038M 16.08% | 187.74M | -1.702M | -0.91% |
| Q2 2024 Q2Q % growth | 172.814M 28.76% | 175.98M | -3.166M | -1.80% |
| Q1 2024 Q2Q % growth | 154.615M 29.79% | 157.18M | -2.565M | -1.63% |
| Q4 2023 Q2Q % growth | 168.412M 31.26% | 172.44M | -4.028M | -2.34% |
| Q3 2023 Q2Q % growth | 160.268M 36.75% | 151.58M | 8.688M | 5.73% |
| Q2 2023 Q2Q % growth | 134.216M 25.44% | 144.87M | -10.654M | -7.35% |
| Q1 2023 Q2Q % growth | 119.126M 39.66% | 118.52M | 606K | 0.51% |
| Q4 2022 Q2Q % growth | 128.3M 40.68% | 129.89M | -1.59M | -1.22% |
| Q3 2022 Q2Q % growth | 117.2M 45.23% | 115.81M | 1.39M | 1.20% |
| Q2 2022 Q2Q % growth | 107M 44.99% | 102.77M | 4.23M | 4.12% |
| Q1 2022 Q2Q % growth | 85.3M 42.88% | 90.324M | -5.024M | -5.56% |
| Q4 2021 Q2Q % growth | 91.2M 61.99% | 91.316M | -116K | -0.13% |
| Q3 2021 Q2Q % growth | 80.7M 76.97% | 81.58M | -880K | -1.08% |
| Q2 2021 Q2Q % growth | 73.8M 94.21% | 70.278M | 3.522M | 5.01% |
| Q1 2021 Q2Q % growth | 59.7M 201.52% | 58.208M | 1.492M | 2.56% |
| Q4 2020 Q2Q % growth | 56.3M | 52.891M | 3.409M | 6.45% |
| Q3 2020 Q2Q % growth | 45.6M | 40.868M | 4.732M | 11.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.75% | -6.19% | 0.3% | 7.22% |
| Revenue | -0.41% | -1.08% | 0.29% | 0.32% |